Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Windtree Therapeutics Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 25 | 1 | 27 | +3 |
| Shares | 1.60M | 4.09K | 1.73M | +135.4K (+8.5%) |
| Value | $664.4K | $2.00K | $518.7K | −$143.7K (−21.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Windtree Therapeutics Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| PVG Asset Management Corp | 187,060 | $56.1K | 0.22% |
| Two Sigma Securities, LLC | 45,999 | $14.0K | 0.00% |
| Susquehanna International Group, LLP | 16,075 | $5.00K | 0.00% |
| Cetera Investment Advisers | 15,255 | $5.00K | 0.00% |
| Game Plan Financial Advisors, LLC | 10,000 | $3.00K | 0.00% |
| Addison Advisors LLC | 166 | $0 | 0.00% |
Sold out (3)
Institutions that held Windtree Therapeutics Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Two Sigma Advisers, LP | 84,700 | $35.0K |
| Captrust Financial Advisors | 1,500 | $1.00K |
| Blue Bell Private Wealth Management, LLC | 5 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Windtree Therapeutics Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 4,087 | $2.00K |